Tobacco Free Initiative (TFI)

The first session of the Conference of the Parties to the
WHO Framework Convention on Tobacco Control


Day 2 - Tue, 7 February

Session continued in plenary with other high-level segment discussion.

The plenary then adopted the procedures for the meeting.

Dr Yumiko Mochizuki, TFI's Director, presented the report of the secretariat on its activities since the second session of the Open-ended Intergovernmental Working Group on the WHO Framework Convention on Tobacco Control (WHO FCTC) (see document: A/FCTC/COP/1/3).

Dr Douglas Bettcher, Coordinator FTC/TFI, presented on the status of the WHO FCTC (see document: A/FCTC/COP/1/INF.DOC./1

Presentation of the Report of the Open-ended Intergovernmental Working Group on the WHO Framework Convention on Tobacco Control by Ambassador Luiz Felipe de Seixas Corrêa, Brazilian Ambassador to Germany, Berlim (see document: A/FCTC/COP/1/DIV/6).

At the end of the session, the officials for the Committees A and B were elected, with a chair and 2 vice chairs. Committee A is chaired by India, and committee B is chaired by Senegal. Committee A deals with Substantive matters and Committee B with institutional, procedural, and budgetary matters (see document: A/FCTC/COP/1/DIV/7).

TFI lunch time seminar:

Tobacco Product Regulation and its ramifications for implementation

Opening Remarks by H.E. Mr Wegger Christian Strømmen, Norway's Ambassador to the UN-Organisations in Geneva, Switzerland.

Dr Tharald Hetland, Senior Adviser, Ministry of Health and Care, Norway Chair & Moderator.

Presenters

Erik Dybing, MD, PhD
Chair of the WHO Study Group on Tobacco Product Regulation (TobReg)
Division Director and Professor Division of Environmental Medicine
Norwegian Institute of Public Health
A presentation on the rationale for establishing tobacco product regulation, including an overview of the mandates and activities of TobReg and TobLabNet.
An overview of the importance of science driven product toxicity assessment to guide regulation, principles of chemical product regulation and complexity of tobacco product regulation will also discussed.

David M. Burns, M.D.
TobReg Member
Professor of Family and Preventive Medicine
Professor of Medicine
UCSD School of Medicine
Presentation on the experience from standardization activities on machine testing of cigarettes, including problems with current ISO-driven communications and why/how they should be replaced to enable compliance with communications requirements under the Framework Convention.

Jack E. Henningfield, Ph.D.
TobReg Member
Vice President, Research and Health Policy
Pinney Associates and Professor and Director Innovators Awards Program
Dept. of Psychiatry and Behavioral Sciences
The Johns Hopkins University School of Medicine
Presentation regarding the vital importance of regulating the diversity of tobacco products that are presently marketed as well as new products that will continue to pour from the tobacco industry pipelines. Information on how tobacco product regulation through science-based implementation of the Framework Convention can contribute to the reduction of tobacco use, and tobacco-caused addiction and disease, and support public health driven communications from manufacturers to consumers.

Ms Gemma Vestal, JD, MPH, MBA, RN
Legal Officer/Scientist
Tobacco Free Initiative
TFI's vision with respect to tobacco product regulation in light of the obligations under Articles 9, 10, & 11 of the Framework Convention.

David Hammond, PhD
Representing the Framework Convention Alliance (FCA)
Assistant Professor
Dept. of Health Studies,
University of Waterloo
A presentation on priorities for product regulation and the implications for consumers. The presentation will include FCA recommendations for establishing a regulatory agenda.

Mr Bejon Misra
CEO Consumer VOICE, INDIA
A presentation on the need for civil society involvement with standardization processes at country level in order to achieve international cigarette testing standards that take into account pubic health concerns.

Share